Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 10, 2018 10:58 AM 2 min read

Buy Goldman, Sell Morgan: A Wall Street Pair Trade

by Shanthi Rexaline Benzinga Editor
Follow

Ahead of their earnings releases, Bernstein recommended pair trade in the institutional brokerage space on Tuesday: buying Goldman Sachs Group Inc (NYSE:GS) and selling Morgan Stanley (NYSE:MS).

The Analyst

Bernstein analyst Christian Bolu initiated coverage of Goldman with an Outperform rating and $300 price target. Morgan Stanley shares were initiated with an Underperform and $51 price target.

The Thesis

The factors that drove outperformance among institutional brokers during the 2003-2006 cycle — such as rising rates, benign credit conditions and deregulation — are once again in play, Bolu said in the initiation note.

More importantly, the analyst said he does not forecast the risks related to complex product innovation that contributed to the 2008 crisis. Instead, Bolu said that since 2006, capital levels have tripled and liquidity has doubled.

After a decade of deleveraging, investment management teams are refocusing on growth, the analyst said. To illustrate his point, the analyst noted that 2017 was the first year since 2006 where every global investment bank grew their balance sheets.

Bernstein prefers institutional brokers to retail, as the "near-perfect" operating conditions that benefited retail brokerage are yielding to the "new normal" of higher volatility and increased deposit competition.

The firm said it believes these risks are not adequately factored into earnings forecasts or valuations.

Outsized Earnings Growth Forecast For Goldman

The revenue recession that has impacted Goldman shares is at an inflection point, Bolu said. Fast-growing "strategic growth" businesses such as investment banking, investment management and lending have overtaken trading as the dominant driver of revenue, the analyst said.

"Execution of growth initiatives and a modest recovery in trading could drive outsized earnings growth and 12-13-percent-plus ROE through 2020."

Below-Consensus Expectations For Morgan

The Morgan Stanley bull case of lending-driven ROE expansion and increasing capital return is at a negative inflection point, Bolu said. The analyst said he expects a significant slowdown in lending growth over the next few years in light of deposit outflows and rapidly rising deposit costs. 

In a stance that's at odds with consensus expectations, the analyst said he expects rising interest rates to hurt growth at Morgan Stanley.

"With regard to capital, expect 2018 CCAR cycle to represent the first down year for buybacks since 2013 and underperform Street expectations." 

In the long run, Morgan Stanley's leverage limits the likelihood of above-peer capital return, according to Bernstein. 

The frim's 2018-2020 forecasts for Morgan Stanley are 5-8 percent below consensus.

The Price Action

Goldman shares have gained about 13 percent over the past year compared to Morgan Stanley's 29 percent-plus gains.

In early trading Tuesday, Goldman shares were rallying 2.7 percent and Morgan Stanley was up 1.9 percent. 

Related Links:

Buckingham Previews Big Bank Earnings: 4 Stocks With The Most Long-Term Upside

'Best-In-Class' Bridgewater Bancshares Has 20% Upside Potential, DA Davidson Says In Bullish Initiation

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorPrice TargetInitiationTop StoriesAnalyst RatingsTrading IdeasBernstein
GS Logo
GSThe Goldman Sachs Group Inc
$905.03-0.01%
Overview
MS Logo
MSMorgan Stanley
$172.250.64%
GS Logo
GSThe Goldman Sachs Group Inc
$905.03-0.01%
Overview
MS Logo
MSMorgan Stanley
$172.250.64%
Comments
Loading...